PMV Pharmaceuticals, Inc., a precision oncology company, engages in the discovery and development of small molecule and tumor-agnostic therapies for p53 mutations in cancer. It's lead product candidate is PC14586, a small molecule that corrects mutant p53 protein containing the Y220C mutation and restores wild-type p53 function. The company was formerly known as PJ Pharmaceuticals, Inc. and changed its name to PMV Pharmaceuticals, Inc. in July 2013. PMV Pharmaceuticals, Inc. was incorporated in 2013 and is based in Princeton, New Jersey.
Date |
For |
Estimate |
Reported |
Surprise |
surprise % |
2024-05-09 |
2024-03 |
-0.35 |
-0.3 |
0.05 |
14.29% |
2024-02-29 |
2023-12 |
-0.39 |
-0.31 |
0.08 |
20.51% |
2024-02-29 |
2023-12 |
-0.39 |
N/A |
N/A |
N/A |
2023-11-09 |
2023-09 |
-0.45 |
-0.34 |
0.11 |
24.44% |
2023-11-09 |
2023-09 |
-0.45 |
N/A |
N/A |
N/A |
2023-08-09 |
2023-06 |
-0.47 |
-0.38 |
0.09 |
19.15% |
Date |
Firm |
Action |
From |
To |
2023-10-15 |
HC Wainwright & Co. |
Upgrade |
Buy |
Buy |
2023-08-10 |
HC Wainwright & Co. |
Upgrade |
Buy |
Buy |
2023-05-16 |
HC Wainwright & Co. |
Upgrade |
Buy |
Buy |
2023-05-10 |
Oppenheimer |
Upgrade |
Outperform |
Outperform |
2023-03-19 |
HC Wainwright & Co. |
Upgrade |
|
Buy |
2023-03-01 |
Oppenheimer |
Upgrade |
|
Outperform |
Date |
Name |
Relation |
Quantity |
Description |
2023-09-14 |
ALLAND LEILA |
Officer |
45.91K |
Sale |
2021-06-13 |
EUCLIDEAN CAPITAL, L.L.C. |
Beneficial Owner of more than 10% of a Class of Security |
0.00 |
Sale |
2021-05-31 |
HEYMAN RICHARD A |
Director |
0.00 |
Sale |
2024-01-17 |
JALOTA DEEPIKA |
Officer |
125.50K |
Stock Award(Grant) |
2022-11-24 |
KUNG WINSTON |
Chief Operating Officer |
10.60K |
Stock Gift |
2021-09-21 |
LEVINE ARNOLD J |
Director |
409.84K |
Sale |
Institution Ownership
...
Report Date |
Organization |
Position |
Value |
Percentage |
2023-06-29 |
Orbimed Advisors LLC. |
6.56M |
41.08M |
13.54% |
2023-06-29 |
Blackrock Inc. |
4.68M |
29.28M |
9.65% |
2023-06-29 |
JP Morgan Chase & Company |
4.08M |
25.51M |
8.41% |
2023-06-29 |
Boxer Capital, LLC |
3.16M |
19.81M |
6.53% |
2023-06-29 |
Avoro Capital Advisors LLC |
3.06M |
19.16M |
6.32% |
2023-06-29 |
RTW Investments LP |
3.03M |
18.96M |
6.25% |
Report Date |
Organization |
Position |
Value |
Percentage |
2023-06-29 |
Vanguard Total Stock Market Index Fund |
1.26M |
7.90M |
2.61% |
2023-06-29 |
JP Morgan Small Cap Growth Fund |
1.23M |
7.73M |
2.55% |
2023-08-30 |
iShares Russell 2000 ETF |
904.22K |
6.53M |
1.87% |
2023-07-30 |
Federated Hermes MDT Small Cap Core Fund |
818.47K |
5.35M |
1.69% |
2023-06-29 |
ACAP Strategic Fund |
709.50K |
4.44M |
1.46% |
2023-06-29 |
Vanguard Extended Market Index Fund |
448.37K |
2.81M |
0.93% |